Cargando…

miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8

Drug resistance remains a large obstacle for the treatment of ovarian cancer. miRNAs have been reported to be involved in cisplatin (CDDP) resistance in ovarian cancer. The aim of the present study was to investigate the function and mechanism of miR-199a-3p in the CDDP resistance in ovarian cancer....

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yajie, Wu, Fengqin, Tian, Defu, Wang, Ting, Lu, Tianjie, Huang, Xiying, Zhang, Peilian, Qin, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868401/
https://www.ncbi.nlm.nih.gov/pubmed/29436681
http://dx.doi.org/10.3892/or.2018.6259

Ejemplares similares